000403.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:04):

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China...

Stats
Dzisiejszy wolumen	3.46M
Średni wolumen	5.61M
Kapitalizacja rynkowa	21.75B
EPS	CNY0.250 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.79
ATR14	CNY0.0320 (0.11%)

Wolumen Korelacja

Długi: 0.07 (neutral)

Krótki: 0.85 (strong)

Signal:(63.153) Same movement expected

Pacific Shuanglin Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pacific Shuanglin Korelacja - Waluta/Towar

0.03
( neutral )

-0.12
( neutral )

0.00
( neutral )

0.05
( neutral )

-0.35
( neutral )

-0.31
( neutral )

Pacific Shuanglin Finanse

Annual	2023
Przychody:	CNY2.33B
Zysk brutto:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2023
Przychody:	CNY2.33B
Zysk brutto:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2022
Przychody:	CNY2.41B
Zysk brutto:	CNY1.25B (52.13 %)
EPS:	CNY0.800

FY	2021
Przychody:	CNY1.97B
Zysk brutto:	CNY908.43M (46.07 %)
EPS:	CNY0.554

Financial Reports:

No articles found.

Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.